Drug Shortage Report for VISIPAQUE 270
| Report ID | 145158 |
| Drug Identification Number | 02145766 |
| Brand name | VISIPAQUE 270 |
| Common or Proper name | Iodixanol injection USP |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IODIXANOL |
| Strength(s) | 550MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
| Packaging size | 50 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-09-03 |
| Actual start date | 2021-09-03 |
| Estimated end date | 2021-09-09 |
| Actual end date | 2021-09-08 |
| Shortage status | Resolved |
| Updated date | 2021-09-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-09-09 | English | Compare |
| v5 | 2021-09-08 | French | Compare |
| v4 | 2021-09-08 | English | Compare |
| v3 | 2021-09-04 | English | Compare |
| v2 | 2021-09-03 | French | Compare |
| v1 | 2021-09-03 | English | Compare |
Showing 1 to 6 of 6